Sociodemographic differences in diagnosis and treatment of pediatric headache

Jack Stevens1, Jeffrey Harman, Ann Pakalnis

  • 1Department of Pediatrics, Ohio State University, Columbus, Ohio 43205, USA. Jack.Stevens@nationwidechildrens.org

Insights

Pediatric headache diagnoses and treatments show sociodemographic disparities. Children with private insurance and minority children were less likely to receive a neurologist diagnosis, and evidence-based medication use was low for all headache patients.

Area of Science:

  • Pediatric healthcare
  • Neurology
  • Health services research

Background:

  • Headaches are a common complaint in pediatric healthcare visits.
  • Understanding sociodemographic disparities in diagnosis and treatment is crucial for equitable care.
  • Previous research has highlighted access and quality variations in pediatric specialty care.

Purpose of the Study:

  • To investigate sociodemographic differences in pediatric headache diagnoses.
  • To examine disparities in neurologist diagnosis and evidence-based medication prescription for pediatric headaches.
  • To identify potential inequities in headache care for children across the U.S.

Main Methods:

  • Utilized two nationally representative databases: National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS).
  • Analyzed pediatric healthcare visits involving a headache diagnosis.
  • Compared diagnosis rates by insurance type and race/ethnicity, and assessed prescription of evidence-based medications.

Main Results:

  • Headache diagnoses were less frequent during visits for privately insured children compared to those with Medicaid.
  • While diagnosis rates were similar for Caucasian, African American, and other racial/ethnic groups, minority children were less likely to see a neurologist.
  • Only 37% of pediatric headache visits resulted in an evidence-based medication prescription.

Conclusions:

  • Sociodemographic factors, including insurance status and race/ethnicity, are associated with disparities in pediatric headache care.
  • There are significant gaps in the utilization of neurologists and evidence-based treatments for pediatric headaches.
  • Further research and interventions are needed to address inequities in pediatric headache management.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...